819 related articles for article (PubMed ID: 2211159)
1. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
Galvao M
Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
[TBL] [Abstract][Full Text] [Related]
2. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibitors in congestive heart failure.
Deedwania PC
Arch Intern Med; 1990 Sep; 150(9):1798-805. PubMed ID: 2132302
[TBL] [Abstract][Full Text] [Related]
4. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
[TBL] [Abstract][Full Text] [Related]
5. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
Sigurdsson A
Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
[TBL] [Abstract][Full Text] [Related]
6. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
[TBL] [Abstract][Full Text] [Related]
7. Evolution of angiotensin-converting enzyme inhibitors.
Wyvratt MJ
Clin Physiol Biochem; 1988; 6(3-4):217-29. PubMed ID: 2849521
[TBL] [Abstract][Full Text] [Related]
8. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
Dzau VJ
Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
Roig E; Perez-Villa F; Morales M; Jiménez W; Orús J; Heras M; Sanz G
Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of chronic heart failure with angiotensin-converting enzyme inhibitors].
Schofer J
Dtsch Med Wochenschr; 1988 Oct; 113(43):1684-9. PubMed ID: 2846252
[No Abstract] [Full Text] [Related]
11. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
Davie AP; Rumley A; Lowe GD; McMurray JJ
Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
[No Abstract] [Full Text] [Related]
12. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
[TBL] [Abstract][Full Text] [Related]
13. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
Schunkert H; Holmer SR; Riegger G
Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
[TBL] [Abstract][Full Text] [Related]
14. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
Groden DL
Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
[TBL] [Abstract][Full Text] [Related]
15. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.
Tsuyuki RT; Yusuf S; Rouleau JL; Maggioni AP; McKelvie RS; Wiecek EM; Wang Y; Pogue J; Teo KK; White M; Avezum A; Latini R; Held P; Lindgren E; Probstfield J
Can J Cardiol; 1997 Dec; 13(12):1166-74. PubMed ID: 9444298
[TBL] [Abstract][Full Text] [Related]
16. [The value of ACE inhibitors in heart failure (mechanism of action)].
Drexler H
Z Kardiol; 1992; 81 Suppl 4():85-91. PubMed ID: 1290308
[TBL] [Abstract][Full Text] [Related]
17. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
[TBL] [Abstract][Full Text] [Related]
18. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
20. [Rational therapy of heart failure].
Werner MG; Schmieder RE
Z Kardiol; 1993; 82 Suppl 4():7-16. PubMed ID: 8147063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
